The Supplementation Therapy in Autism and Response to Treatment Study

NCT06187090 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Autism
Autism Spectrum Disorder
Autism Spectrum Disorder High-Functioning
Asperger Syndrome
Depressive Symptoms
Anxiety State

Interventions

DIETARY_SUPPLEMENT: Oral Ultramicronized-Palmitoylethanolamide (um-PEA; 600 mg per day) in tablet form

Sponsor

University of Udine